PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT DERMATA THERAPEUTICS, INC.Securities Agreement • May 17th, 2024 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 17th, 2024 Company Industry JurisdictionTHIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until 5:00 p.m. (New York City time) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 21, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain engagement letter, dated May 14, 2024, by and between the Company and H.C. Wainwright & Co., L
SERIES A/SERIES B] COMMON STOCK PURCHASE WARRANT DERMATA THERAPEUTICS, INC.Security Agreement • May 17th, 2024 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 17th, 2024 Company Industry JurisdictionTHIS [SERIES A/SERIES B] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until 5:00 p.m. (New York City time) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [___]1 2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).